MediciNova, Inc.

• MediciNova, Inc. Estimates – BOATS:MNOV
  TradingView · 23 Oct 2026
• MediciNova’s MN-001 trial misses primary endpoints in NAFLD By Investing.com
  Investing.com Canada · 12 Oct 2026
• MediciNova reports encouraging Phase 2 trial re...
  Pluang · 12 Oct 2026
• MediciNova to Participate in the Maxim Growth Summit
  GlobeNewswire · 06 Oct 2026
• 3D Investment Partners Cuts Stake In Medicinova To 9.88% From 11.22%, Filing Shows
  TradingView · 02 Oct 2026
• H.C. Wainwright reiterates Buy on MediciNova stock, $10 target
  Investing.com · 29 Sep 2026
• MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
  GlobeNewswire · 28 Sep 2026
• MediciNova stock tumbles on mixed Phase 2 NAFLD trial data
  Investing.com · 28 Sep 2026
• MediciNova misses both Phase 2 endpoints despite HDL gains
  Mugglehead Investment Magazine · 28 Sep 2026
• Why is MediciNova stock sliding today?
  Investing.com · 28 Sep 2026
• Form 8K MediciNova Inc For: 28 September By Investing.com
  Investing.com UK · 28 Sep 2026
• MediciNova Announces Completion of Last Patient, Last Visit
  GlobeNewswire · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →